English
Français
Español
Deutsch
Italiano
Bezlotoxumab Biosimilar – Anti-toxin B mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system |
Description of Bezlotoxumab Biosimilar - Anti-toxin B mAb - Research Grade
Description of Bezlotoxumab Biosimilar - Anti-toxin B mAb - Research Grade
General information on Anti-toxin B[Clostridium difficile] (Bezlotoxumab) Monoclonal Antibody
Bezlotoxumab is a human monoclonal antibody that targets Clostridium difficile toxin B and inhibits its activity. Bezlotoxumab is used to reduce the frequency of Clostridium difficle infection in adults.
| Product name | Bezlotoxumab Biosimilar - Anti-toxin B mAb - Research Grade |
|---|---|
| Source | CAS 1246264-45-8 |
| Species | Homo sapiens |
| Purity | >95% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | MK-6072,CDB-1,MDX-1388,MK-3415A (combination of actoxumab and bezlotoxumab),formerly CDB 1 |
| Reference | PX-TA1286 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
| Source | CAS 1246264-45-8 |
| Product name | Bezlotoxumab Biosimilar - Anti-toxin B mAb - Research Grade |
|---|---|
| Source | CAS 1246264-45-8 |
| Species | Homo sapiens |
| Expression system | Mammalian cells |
| Purity | >95% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | MK-6072,CDB-1,MDX-1388,MK-3415A (combination of actoxumab and bezlotoxumab),formerly CDB 1 |
| Reference | PX-TA1286 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
| Source | CAS 1246264-45-8 |
Reviews
There are no reviews yet.